Spermosens will be the 17th SmiLe company to launch an IPO Search jobs Spermosens will be the 17th SmiLe company to launch an IPO Spermosens’ first product, JUNO- Checked, will make it possible for the first time to determine whether the man in a couple with fertility problems is fertile. The company believes that IVF clinics around the world will be able to use its technology to enable more infertile couples to immediately receive the right treatment. Now Spermosens will accelerate its development and become listed on the Spotlight Stock Market in early May. The company is a member of SmiLe Incubator.